GlassScriptPhysician profile
Timothy J Tausch
NPI 1477751378
$11,160.55
in general payments reported to CMS, 2019-2025
21 companies · $2,270 in 2025
The $2,270 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,791 · 2020: $12.02 · 2021: $52.17 · 2022: $1,406 · 2023: $548 · 2024: $1,081 · 2025: $2,270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,112 · Travel and Lodging: $1,787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,111.93 |
| Travel and Lodging | $1,787.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $7,225.08 | 2019-2025 | Lithovue, Axonics, Spaceoar Vue System - 10ml |
| Procept Biorobotics Corporation | $1,477.91 | 2023-2025 | Aquabeam Robotic System |
| Teleflex LLC | $1,451.46 | 2022-2025 | Urolift |
| Endo Pharmaceuticals INC. | $275.63 | 2019-2023 | Xiaflex, Aveed, Edex |
| Urogen Pharma, INC. | $166.69 | 2020-2023 | Jelmyto |
| Urovant Sciences INC | $99.83 | 2022 | |
| Laborie Medical Technologies Corp. | $89.21 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology |
| Antares Pharma, INC. | $62.23 | 2025 | Xyosted |
| Sumitomo Pharma America, INC. | $49.13 | 2023 | Gemtesa |
| Convatec INC. | $33.11 | 2024 | |
| Coloplast Corp | $31.66 | 2022 | |
| Progenics Pharmaceuticals, INC. | $28.75 | 2025 | |
| Genzyme Corporation | $24.21 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $22.66 | 2022 | |
| Endo USA, INC. | $21.35 | 2025 | Xiaflex |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $21.00 | 2022 | |
| Immunitybio, INC. | $19.94 | 2025 | |
| Dendreon Pharmaceuticals LLC | $17.34 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.72 | 2023 | |
| Olympus America INC. | $13.43 | 2022 | |
| Acerus Pharmaceuticals Corporation | $13.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Tausch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.